Bishvanwesha Panda

Bishvanwesha Panda

Auto-generated profile, based on publicly available information

Bishvanwesha Panda

Research School of Chemistry, Australian National University, Canberra 2601, ACT, Australia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SUSven Ullrich
Sven Ullrich
BPBishvanwesha Panda
Bishvanwesha Panda
USUpamali Somathilake
Upamali Somathilake
DLDouglas J. Lawes
Douglas J. Lawes
CNChristoph Nitsche
Christoph Nitsche
The bifunctional reagent 2-chloromethyl-6-cyanopyridine enables biocompatible, non-symmetric stapling of N-terminal and internal cysteines. Stapled peptides exhibit improved affinity, inhibition and stability and can be displayed on proteins.

17 January 2025 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SUSven Ullrich
Sven Ullrich
SKSanthanalaxmi Kumaresan
Santhanalaxmi Kumaresan
MRMarina G. Rahman
Marina G. Rahman
BPBishvanwesha Panda
Bishvanwesha Panda
RMRichard Morewood
Richard Morewood
CNChristoph Nitsche
Christoph Nitsche
A small molecular adapter enables site-specific peptide–protein conjugation via cysteine modification and cyanopyridine–aminothiol reactions, yielding complex branched or cyclic architectures for potential protein therapeutics.

10 December 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
SUSven Ullrich
Sven Ullrich
SKSanthanalaxmi Kumaresan
Santhanalaxmi Kumaresan
MRMarina Rahman
Marina Rahman
BPBishvanwesha Panda
Bishvanwesha Panda
RMRichard Morewood
Richard Morewood
CNChristoph Nitsche
Christoph Nitsche
A two-step, biocompatible strategy enables site-specific generation of branched and macrocyclic peptide–protein conjugates. Surface-exposed cysteines on proteins are modified by a small bifunctional reagent at near-physiological pH, followed by cyanopyridine–aminothiol click reactions to create branched or macrocyclic peptide architectures. This method offers design strategies for next-generation protein therapeutics.